Tearsheet

Clorox (CLX)

Market Price (12/18/2025): $101.5 | Market Cap: $12.4 Bil
Sector: Consumer Staples | Industry: Household Products

Clorox (CLX)

Market Price (12/18/2025): $101.5
Market Cap: $12.4 Bil
Sector: Consumer Staples
Industry: Household Products

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.1%	Weak multi-year price returns 2Y Excs Rtn is -68%, 3Y Excs Rtn is -93%	Weak revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -9.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.1%, Rev Chg QQuarterly Revenue Change % is -19%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13%		Key risks CLX key risks include [1] significant operational disruption and financial impact from its major ERP system transition and [2] widespread business interruption stemming from a recent cyberattack.
2	Low stock price volatility Vol 12M is 23%
3	Megatrend and thematic drivers Megatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more.

0	Attractive yield Total YieldTotal Yield = Earnings Yield + Dividend Yield, Earnings Yield = Net Income / Market Cap Dividend Yield = Total Dividends / Market Cap is 7.2%, ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is 3.1%
1	Attractive cash flow generation CFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is 13%
2	Low stock price volatility Vol 12M is 23%
3	Megatrend and thematic drivers Megatrends include Health & Wellness Trends, and Sustainable Consumption. Themes include Nutritional Supplements, Organic & Natural Products, Show more.
4	Weak multi-year price returns 2Y Excs Rtn is -68%, 3Y Excs Rtn is -93%
5	Weak revenue growth Rev Chg LTMRevenue Change % Last Twelve Months (LTM) is -9.3%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -1.1%, Rev Chg QQuarterly Revenue Change % is -19%
6	Key risks CLX key risks include [1] significant operational disruption and financial impact from its major ERP system transition and [2] widespread business interruption stemming from a recent cyberattack.

Valuation, Metrics & Events

	12/18/25	2024	2023	2022
Share Price CYE	$101.50	$156.53	$132.97	$126.66
Market Cap CYE ($ Bil)	12.4	19.4	16.5	15.6
Total Debt ($ Bil)	3.1	2.9	2.9	2.9
Total Cash ($ Bil)	0.2	0.2	0.2	0.4
Enterprise Value ($ Bil)	15.4	22.3	19.4	18.5
Valuation Ratios
P/S TTM	2.2	2.8	2.5	2.4
P/EBIT TTM	13.8	17.2	36.3	52.9
P/E TTM	19.1	24.8	63.2	116.4
Sector Ratios
P/S TTM (Sector)	0.9	1.0	0.9	0.9
P/EBIT TTM (Sector)	10.3	10.7	11.6	11.4
P/E TTM (Sector)	12.7	14.4	15.9	14.3

	12/18/25	2024
Share Price CYE	$101.50	$156.53
Market Cap CYE ($ Bil)	12.4	19.4
Total Debt ($ Bil)	3.1	2.9
Total Cash ($ Bil)	0.2	0.2
Enterprise Value ($ Bil)	15.4	22.3
Valuation Ratios
P/S TTM	2.2	2.8
P/EBIT TTM	13.8	17.2
P/E TTM	19.1	24.8
Sector Ratios
P/S TTM (Sector)	0.9	1.0
P/EBIT TTM (Sector)	10.3	10.7
P/E TTM (Sector)	12.7	14.4

	CLX	S&P 500
REVENUE GROWTH	VERY POOR
Rev LTM ($ Bil)	6.8
Rev Chg Q	-18.9%	7.3%
Rev Chg LTM	-9.3%	6.0%
Rev Chg 3Y Avg	-1.1%	5.5%
PROFITABILITY	FAIR
Op Inc LTM ($ Bil)	1.0
CFO LTM ($ Bil)	0.9
Net Inc LTM ($ Bil)	0.8
Op Mgn LTM	14.9%	18.8%
CFO/Rev LTM	12.6%	20.4%
Net Inc Mgn	11.7%	13.1%
VALUATION	MODERATE
P/S	2.2	3.2
P/CFO	17.7	16.0
P/FCF	23.8	20.7
P/E	19.1	23.5
STABILITY	GOOD
Debt/Equity	0.20	0.21
Cash/Assets	0.03	0.07

AI Generated Analysis | Feedback

Metric	Value	Date	Source
Market Share Leadership	Approximately 80% of brands hold the #1 or #2 market share position in their respective categories.	12012023	Link
Bleach Market Share	70%	12012023	Link
Charcoal Market Share	50%	12012023	Link
Trash Bag Market Share	33.3%	12012023	Link
Recyclable, Reusable or Compostable Packaging Goal Progress	88% of goal to have 100% recyclable, reusable or compostable packaging by 2025.	2222024	Link
Scope 1 and 2 Greenhouse Gas Emissions Reduction	Greater than 65% reduction versus 2020 base year.	9032024	Link
Scope 3 Greenhouse Gas Emissions Reduction	Greater than 15% reduction in category 1 (purchased goods and services) and category 11 (use of sold products) against a 2020 baseline.	9032024	Link
Zero-Waste-to-Landfill Facilities	More than half of facilities and almost 80% of plants have attained zero-waste-to-landfill status.	9032024	Link
Recordable Incident Rate	0.47	9032024	Link
Consumer Reach	Achieved 2025 goal of knowing 100 million consumers.	9032024	Link
Board of Directors Diversity - Female Representation	50%	2222024	Link
Board of Directors Diversity - People of Color Representation	25%	2222024	Link

Upcoming
1/28/2026	Dividend	Amount: $1.24 Payment On: 2/13/2026
2/02/2026	Earnings Release	Rev: $1.0 Bil (E) EPS: $1.46 (E)

CLX Stock

Return (1M):

Why The Stock Moved

Qualitative Assessment

AI Generated Analysis | Feedback

Between August 31, 2025, and December 18, 2025, The Clorox Company (CLX) experienced a decline in its stock price, influenced by several key factors: 1. Weakening Consumer Sentiment and Macroeconomic Headwinds

The company faced challenges from weakening U.S. consumer sentiment and broader macroeconomic and geopolitical uncertainties, which directly impacted consumer purchasing behavior, particularly in core categories like household cleaning and grilling products. These market conditions made investors more selective, favoring companies with clear growth drivers over those facing rising costs or stalling growth. 2. Impact of Strategic Divestitures

Clorox's strategic decision to divest its Better Health Vitamins, Minerals, and Supplements (VMS) business and its operations in Argentina significantly reduced net sales. The sale of the Argentina business alone resulted in a pretax charge of $240 million in Q3 fiscal year 2024. These divestitures, while strategic, contributed to lower reported revenues. 3. Challenges from ERP System Transition

The implementation of a new Enterprise Resource Planning (ERP) system introduced service disruptions that affected organic sales growth. Although Clorox pulled forward shipments in Q1 fiscal year 2025 to mitigate these disruptions, the subsequent unwinding of these incremental shipments was expected to negatively impact future sales, forecasting revenue declines for fiscal year 2026. 4. Lower Sales Volumes and Revenue Declines

The company experienced lower-than-expected sales volumes and overall revenue declines across several key segments. For instance, net sales decreased 6% in Q4 fiscal year 2024, and Q2 fiscal year 2025 revenues declined 15% year over year due to broad-based declines across segments like Health and Wellness, Household, Lifestyle, and International. Analysts projected a year-over-year decline in earnings on lower revenues for the quarter ended September 2025. 5. Analyst Downgrades and Revised Outlooks

Several financial analysts downgraded Clorox's ratings and lowered their price targets during this period. Citigroup, for example, maintained a "Neutral" rating but lowered its price target from $120.00 to $109.00 in December 2025, a 9.17% reduction. Other firms like JP Morgan, Wells Fargo, and Morgan Stanley also reduced their price targets in November 2025, reflecting evolving perspectives on Clorox's market position and potential financial performance. The consensus analyst rating for Clorox remained "Hold".

Show less

Stock Movement Drivers

Fundamental Drivers

The -18.2% change in CLX stock from 9/17/2025 to 12/17/2025 was primarily driven by a -16.6% change in the company's P/E Multiple.

	9172025	12172025	Change
Stock Price ($)	124.10	101.52	-18.20%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7104.00	6771.00	-4.69%
Net Income Margin (%)	11.40%	11.68%	2.46%
P/E Multiple	18.87	15.74	-16.60%
Shares Outstanding (Mil)	123.17	122.63	0.44%
Cumulative Contribution			-18.20%

LTM = Last Twelve Months as of date shown

Market Drivers

9/17/2025 to 12/17/2025

	Return	Correlation
CLX	-18.2%
Market (SPY)	1.9%	-1.6%
Sector (XLP)	-0.7%	59.4%

Fundamental Drivers

The -14.3% change in CLX stock from 6/18/2025 to 12/17/2025 was primarily driven by a -25.3% change in the company's P/E Multiple.

	6182025	12172025	Change
Stock Price ($)	118.47	101.52	-14.31%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7019.00	6771.00	-3.53%
Net Income Margin (%)	9.89%	11.68%	18.15%
P/E Multiple	21.06	15.74	-25.27%
Shares Outstanding (Mil)	123.37	122.63	0.60%
Cumulative Contribution			-14.31%

LTM = Last Twelve Months as of date shown

Market Drivers

6/18/2025 to 12/17/2025

	Return	Correlation
CLX	-14.3%
Market (SPY)	12.7%	8.8%
Sector (XLP)	-0.3%	58.8%

Fundamental Drivers

The -35.5% change in CLX stock from 12/17/2024 to 12/17/2025 was primarily driven by a -71.2% change in the company's P/E Multiple.

	12172024	12172025	Change
Stock Price ($)	157.41	101.52	-35.51%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7469.00	6771.00	-9.35%
Net Income Margin (%)	4.78%	11.68%	144.41%
P/E Multiple	54.58	15.74	-71.17%
Shares Outstanding (Mil)	123.80	122.63	0.94%
Cumulative Contribution			-35.51%

LTM = Last Twelve Months as of date shown

Market Drivers

12/17/2024 to 12/17/2025

	Return	Correlation
CLX	-35.5%
Market (SPY)	12.1%	19.5%
Sector (XLP)	-0.3%	63.0%

Fundamental Drivers

The -22.2% change in CLX stock from 12/18/2022 to 12/17/2025 was primarily driven by a -60.4% change in the company's P/E Multiple.

	12182022	12172025	Change
Stock Price ($)	130.51	101.52	-22.21%
Change Contribution By	LTM	LTM
Total Revenues ($ Mil)	7041.00	6771.00	-3.83%
Net Income Margin (%)	5.75%	11.68%	103.10%
P/E Multiple	39.75	15.74	-60.40%
Shares Outstanding (Mil)	123.34	122.63	0.58%
Cumulative Contribution			-22.22%

LTM = Last Twelve Months as of date shown

Market Drivers

12/18/2023 to 12/17/2025

	Return	Correlation
CLX	-23.8%
Market (SPY)	44.9%	15.3%
Sector (XLP)	16.0%	57.9%

Return vs. Risk

Price Returns Compared

	2020	2021	2022	2023	2024	2025	Total [1]
Returns
CLX Return	34%	-11%	-17%	5%	18%	-36%	-22%
Peers Return	16%	12%	-14%	11%	15%	-9%	30%
S&P 500 Return	16%	27%	-19%	24%	23%	14%	108%
Monthly Win Rates [3]
CLX Win Rate	58%	42%	50%	58%	50%	17%
Peers Win Rate	57%	53%	38%	52%	63%	35%
S&P 500 Win Rate	58%	75%	42%	67%	75%	73%
Max Drawdowns [4]
CLX Max Drawdown	-1%	-20%	-29%	-15%	-9%	-37%
Peers Max Drawdown	-20%	-9%	-27%	-7%	-1%	-15%
S&P 500 Max Drawdown	-31%	-1%	-25%	-1%	-2%	-15%

[1] Cumulative total returns since the beginning of 2020
[2] Peers: PG, CL, KMB, CHD, ECL. See CLX Returns vs. Peers.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)

How Low Can It Go

Unique Key	Event	CLX	S&P 500
2022 Inflation Shock	2022 Inflation Shock
2022 Inflation Shock% Loss	% Loss	-48.1%	-25.4%
2022 Inflation Shock% Gain to Breakeven	% Gain to Breakeven	92.6%	34.1%
2022 Inflation ShockTime to Breakeven	Time to Breakeven	Not Fully Recovered days	464 days
2020 Covid Pandemic	2020 Covid Pandemic
2020 Covid Pandemic% Loss	% Loss	-18.0%	-33.9%
2020 Covid Pandemic% Gain to Breakeven	% Gain to Breakeven	22.0%	51.3%
2020 Covid PandemicTime to Breakeven	Time to Breakeven	Not Fully Recovered days	148 days
2018 Correction	2018 Correction
2018 Correction% Loss	% Loss	-23.3%	-19.8%
2018 Correction% Gain to Breakeven	% Gain to Breakeven	30.4%	24.7%
2018 CorrectionTime to Breakeven	Time to Breakeven	136 days	120 days
2008 Global Financial Crisis	2008 Global Financial Crisis
2008 Global Financial Crisis% Loss	% Loss	-33.0%	-56.8%
2008 Global Financial Crisis% Gain to Breakeven	% Gain to Breakeven	49.2%	131.3%
2008 Global Financial CrisisTime to Breakeven	Time to Breakeven	583 days	1480 days

Compare to PG, CL, KMB, ENTG, EPC

In The Past

Clorox's stock fell -48.1% during the 2022 Inflation Shock from a high on 1/27/2021. A -48.1% loss requires a 92.6% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Clorox (CLX)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brand names; professional cleaning and disinfecting products under the CloroxPro, Clorox Healthcare, and Clorox Total 360 brand names; professional food service products under the Hidden Valley brand name; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brand names in the United States. The Household segment provides cat litter products under the Fresh Step, Scoop Away, and Ever Clean brand names; bags and wraps under the Glad brand name; and grilling products under the Kingsford and Kingsford Match Light brand names in the United States. The Lifestyle segment offers dressings, dips, seasonings, and sauces primarily under the Hidden Valley brand name; natural personal care products under the Burt's Bees brand name; and water-filtration systems and filters under the Brita brand name in the United States. The International segment provides laundry additives; home care products; water-filtration systems and filters; digestive health products; grilling products; cat litter products; food products; bags and wraps; natural personal care products; and professional cleaning and disinfecting products internationally primarily under the Clorox, Ayudin, Clorinda, Poett, Pine-Sol, Glad, Brita, RenewLife, Ever Clean and Burt's Bees brand names. The Clorox Company sells its products primarily through mass retailers, grocery outlets, warehouse clubs, dollar stores, home hardware centers, third-party and owned e-commerce channels, military stores, and distributors, as well as a direct sales force. The company was founded in 1913 and is headquartered in Oakland, California.

AI Generated Analysis | Feedback

Here are 1-3 brief analogies for Clorox:

The Procter & Gamble of household cleaning, charcoal, and pet care products.
Like Unilever, but specializing in brands ranging from Clorox bleach to Burt's Bees and Glad bags.

AI Generated Analysis | Feedback

Clorox Bleach & Cleaning Products: Disinfecting bleaches, wipes, and sprays used for household cleaning and sanitation.
Pine-Sol: Multi-surface cleaners known for their distinctive scent and ability to tackle tough messes.
Glad: Plastic bags, wraps, and containers for food storage, trash management, and general household use.
Kingsford: Charcoal briquets and grilling accessories primarily used for outdoor cooking.
Hidden Valley Ranch: Salad dressings, dips, and seasoning mixes, most famously the original ranch flavor.
Fresh Step: Cat litter products designed to control odors and provide a comfortable environment for pets.
Brita: Water filtration systems, including pitchers, dispensers, and faucet filters, to improve tap water quality.
Burt's Bees: Natural personal care products, such as lip balms, skincare, and bath products.

AI Generated Analysis | Feedback

Clorox (CLX) sells primarily to other companies, specifically major retail chains and e-commerce platforms that distribute its products to individual consumers.

According to its most recent annual filings, Clorox's major customers are:

Walmart Inc. (Symbol: WMT)
The Kroger Co. (Symbol: KR)
Amazon.com, Inc. (Symbol: AMZN)

AI Generated Analysis | Feedback

null

AI Generated Analysis | Feedback

Linda Rendle, Chair and CEO

Linda Rendle was named CEO of The Clorox Company in September 2020 and added responsibilities as chair of the board in January 2024. She has been with Clorox for over 20 years, holding various senior leadership positions. Prior to becoming CEO, she served as president, overseeing all of the company's businesses, corporate and business development, corporate strategy, and five core global functions. Her roles at Clorox have also included executive vice president – Cleaning, International, Strategy and Operations, and vice president and general manager – Home Care. Before joining Clorox in 2003, Rendle worked for The Procter & Gamble Company in sales management.

Luc Bellet, Executive Vice President and Chief Financial Officer

Luc Bellet was appointed Executive Vice President and Chief Financial Officer of The Clorox Company, effective April 1, 2025. He has been with Clorox for over 18 years, most recently serving as the company's treasurer. Bellet has held various leadership roles across Clorox's financial organization, including financial planning and analysis, internal audit, and business development.

Nina Barton, Executive Vice President and Group President – Care & Connection

Nina Barton is the Executive Vice President and Group President – Care & Connection at Clorox.

Angela Hilt, Executive Vice President and Chief Legal and External Affairs Officer and Corporate Secretary

Angela Hilt serves as Executive Vice President and Chief Legal and External Affairs Officer and Corporate Secretary for The Clorox Company.

Chris Hyder, Executive Vice President and Group President — Health & Hygiene

Chris Hyder is the Executive Vice President and Group President — Health & Hygiene at Clorox.

AI Generated Analysis | Feedback

The Clorox Company (CLX) faces several key risks to its business operations and financial performance.

Key Risks to Clorox (CLX)

Operational Disruptions from ERP Transition and Cyberattack: Clorox is experiencing significant operational challenges stemming from a major Enterprise Resource Planning (ERP) system transition in the U.S. This transition is projected to cause a 7% to 8% decline in year-over-year sales and reduce fiscal year 2026 earnings per share by $0.85 to $0.95. This operational "hangover" is leading to short-term volatility in financial reports and an inventory drawdown. Further compounding operational risks, Clorox experienced a cyberattack in August 2023 that resulted in widespread disruption to its IT systems. This incident necessitated manual order processing, temporary shutdowns of some operations, and product shortages, materially impacting its fiscal first-quarter financial performance.
Intense Competition and Shifting Consumer Preferences: Clorox operates within a highly competitive market against major players such as Procter & Gamble, Kimberly-Clark, and Unilever. This competitive environment can lead to price wars, reduced profit margins, and a potential loss of market share. Additionally, macroeconomic uncertainty is driving consumers to be more value-seeking, leading to shifts in purchasing channels and sluggish growth in certain product categories, including trash bags and cat litter. The increasing threat of private label brands also intensifies competitive pressure.
Inflationary Pressures and Tariffs: The company continues to navigate ongoing external cost pressures, with inflationary pressures directly impacting its gross margins. Furthermore, Clorox faces an estimated annual impact of $100 million due to tariffs on its cost of goods sold, presenting a significant challenge to its profitability. While management is implementing strategies like recalibrated promotions and cost-saving measures, the persistent nature of these tariffs remains a continuous hurdle.

AI Generated Analysis | Feedback

The rapid growth of direct-to-consumer (DTC) and subscription-based brands specializing in eco-friendly, refillable, and plant-based cleaning and household products, which are capturing market share by appealing to evolving consumer preferences for sustainability and convenience.

AI Generated Analysis | Feedback

Addressable Market Sizes for Clorox's Main Products:

Household Cleaning Products (e.g., Clorox Disinfecting Wipes, Clorox Bleach):
- Global Household Cleaning Products Market: USD 270.36 billion in 2024, projected to reach USD 379.76 billion by 2032.
- U.S. Household Cleaning Products Market: Projected to reach an estimated value of USD 85.22 billion by 2032.
- Global Wipes Market: Valued at USD 4.86 billion in 2024, projected to reach USD 8.04 billion by 2032.
- U.S. Wet Wipes Market: Generated USD 6,954.3 million in 2022 and is expected to reach USD 8,542.5 million by 2030.
- Global Bleaching Agents Market: Estimated at USD 887.7 million in 2022 and projected to reach USD 1,350.1 million by 2030.
Cat Litter Products (e.g., Fresh Step, Scoop Away):
- Global Cat Litter Products Market: Estimated at USD 16.41 billion in 2024 and projected to reach USD 22.31 billion by 2030.
- U.S. Cat Litter Products Market: Estimated at USD 4.53 billion in 2024 and projected to reach USD 5.74 billion by 2030.
Grilling Charcoal (e.g., Kingsford):
- Global BBQ Charcoal Market: Stood at US$ 3.25 billion in 2023, projected to reach US$ 5.24 billion by 2033.
- North America BBQ Charcoal Market: Accounted for approximately 48% market share in 2021.
Water Filtration Products (e.g., Brita):
- Global Water Purifier Market: Valued at USD 35.01 billion in 2024, projected to grow to USD 62.88 billion by 2032.
- U.S. Water Purifier Market: Projected to reach an estimated value of USD 10.63 billion by 2032.
- Global Home Water Filtration Unit Market: Valued at USD 12.12 billion in 2022 and projected to reach USD 26.73 billion by 2030.
Natural Personal Care Products (e.g., Burt's Bees):
- Global Natural and Organic Personal Care Market: Generated a revenue of US$ 28.4 billion in 2025, projected to top US$ 54.3 billion by 2032.
- U.S. Natural and Organic Personal Care Market: Projected to be worth US$ 2,222.2 million (US$ 2.22 billion) in 2024.
Insect Repellents (e.g., Repel, STEM):
- Global Insect Repellent Market: Estimated at USD 5.57 billion in 2024 and projected to reach USD 8.28 billion by 2030.
- U.S. Insect Repellent Market: Generated a revenue of USD 376.9 million in 2024 and is expected to reach USD 540.6 million by 2030.
Food Bags and Wraps (e.g., Glad):
- null

AI Generated Analysis | Feedback

The Clorox Company (CLX) is expected to drive future revenue growth over the next 2-3 years through several strategic initiatives:

Product Innovation and New Launches: Clorox plans to introduce new innovations across its major brands, including Glad, Brita, and Burt's Bees, with further product developments anticipated in the latter half of fiscal year 2026 to maintain competitiveness and drive growth. Analysts also note that upcoming product innovation, particularly in premium and wellness platforms, aims to regain market share and foster organic growth.
Strategic Pricing and Margin Management: The company is leveraging disciplined pricing actions and a comprehensive margin-management program to support growth and mitigate cost pressures. Clorox's multi-faceted pricing policy includes premium pricing for core brands and strategic adjustments in categories supported by value and innovation.
Digital Transformation and ERP System Benefits: The successful launch of a new ERP (Enterprise Resource Planning) system in the U.S. is a critical enhancement to Clorox's digital infrastructure. This system is expected to unlock new value streams, strengthen operational capabilities, improve efficiency, and drive sustained margin gains over the next several years.
Reinvigorating Category Growth and Market Share Recovery: After facing disruptions, Clorox is focused on regaining market share and stimulating category growth. The company aims for positive low single-digit organic sales growth in the second half of the fiscal year 2026 and a return to historical category growth rates of 2-2.5%. Efforts are particularly noted in areas like the Glad brand and the Professional Products Division (PPD).
International Market Expansion and Stability: Clorox's international business has shown growth above the company's sales average. The divestiture of the Argentina business is anticipated to reduce volatility and create more stability and growth opportunities in other parts of the world.

AI Generated Analysis | Feedback

Share Repurchases

Clorox had $75 million in share repurchases for the quarter ending June 30, 2025.
Annual share repurchases for fiscal year 2022 were $25 million.
The company has an authorized open-market share repurchase program of up to $2 billion, which was approved in May 2018 and has no expiration date.

Share Issuance

Clorox's issuance of common stock for the latest twelve months ending June 30, 2025, was $26 million.
The average annual issuance of common stock for fiscal years ending June 2021 to 2025 was $33.6 million.
Share issuance peaked at $103 million in fiscal year 2021.

Outbound Investments

Clorox divested its Better Health Vitamins, Minerals and Supplements (VMS) business.
The company also divested its business operations in Argentina.
Clorox is in the process of settling its Glad joint venture with Procter & Gamble, where it will acquire P&G's 20% stake.

Capital Expenditures

Clorox's capital expenditures for the latest twelve months ending June 30, 2025, were $220 million.
Capital expenditures averaged $248.4 million for fiscal years ending June 2021 to 2025.
The company is investing $500 million over the next few years in transformative technologies and processes, including a new enterprise resource planning (ERP) system and a transition to a cloud-based platform, with these investments commencing in fiscal year 2022.

Better Bets than Clorox (CLX)

	CLX	Better Performance than CLX
Metric	Value	INDUSTRY: Household Products
Rev Chg LTM	-9.3%	WDFC (5.0%), CHD (1.1%), REYN (0.8%), CL (0.1%), KMB (-3.1%)
Rev Chg 3Y Avg	-1.1%	IPAR (14.7%), WDFC (6.2%), CHD (4.6%), CL (4.2%), REYN (-0.4%)
Op Mgn LTM	14.9%	CL (21.7%), IPAR (19.3%), CHD (17.8%), WDFC (16.7%), KMB (16.7%)
CFO/Rev LTM	12.6%	CL (19.6%), CHD (17.7%), KMB (15.2%), WDFC (14.2%), IPAR (14.1%)
FCF/Rev LTM	9.4%	CL (16.9%), CHD (15.3%), WDFC (13.5%), KMB (11.1%), IPAR (9.7%)
Total Yield	7.2%	KMB (9.9%), REYN (9.6%), IPAR (8.4%), CENT (7.8%), CL (7.3%)
P/S	2.2	ENR (0.5), CENT (0.7), REYN (1.4), IPAR (2.2), KMB (2.2)
P/Op Inc	15.0	CENT (8.3), REYN (10.2), IPAR (11.2), KMB (13.1), CL (14.9)

	CLX	Better Performance than CLX
Metric	Value	SECTOR: Consumer Staples
Rev Chg LTM	-9.3%	COST (8.2%), PM (7.5%), WMT (4.3%), KO (2.8%), PG (1.2%)
Rev Chg 3Y Avg	-1.1%	PM (8.0%), COST (6.6%), WMT (5.4%), KO (4.0%), PG (1.8%)
Op Mgn LTM	14.9%	MO (59.0%), PM (37.1%), KO (31.3%), BUD (26.1%), PG (24.1%)
CFO/Rev LTM	12.6%	MO (43.8%), PM (28.8%), PG (22.3%), KO (16.0%), PEP (12.7%)
FCF/Rev LTM	9.4%	MO (43.1%), PM (25.3%), MNST (24.4%), PG (17.6%), KO (11.7%)
Total Yield	7.2%	MO (14.1%), PEP (7.7%), KO (7.5%), MDLZ (7.4%), CL (7.3%)
P/S	2.2	WMT (1.2), COST (1.5), BUD (2.0), PEP (2.1), MDLZ (2.1)
P/Op Inc	15.0	BUD (7.7), MO (9.3), KDP (10.0), SYY (12.8), CL (14.9)

	CLX	Better Performance than CLX
Metric	Value	ALL OTHER SECTORS
Rev Chg LTM	-9.3%	NVDA (65.2%), MSFT (15.6%), GOOGL (13.4%), AMZN (10.9%), AAPL (6.0%)
Rev Chg 3Y Avg	-1.1%	NVDA (91.6%), MSFT (13.2%), AMZN (11.3%), GOOGL (11.0%), AAPL (1.8%)
Op Mgn LTM	14.9%	NVDA (58.8%), MSFT (46.3%), META (43.2%), GOOGL (32.2%), AAPL (31.9%)
CFO/Rev LTM	12.6%	MSFT (50.0%), NVDA (44.4%), GOOGL (39.3%), AAPL (26.6%), AMZN (18.1%)
FCF/Rev LTM	9.4%	NVDA (41.3%), MSFT (26.6%), META (23.7%), AAPL (23.5%), GOOGL (19.1%)
Total Yield	7.2%	WFC (9.9%), XOM (9.8%), JNJ (8.4%), UNH (8.1%), BAC (7.7%)
P/S	2.2	UNH (0.7), XOM (1.5), CVX (1.6), HD (2.1), C (2.2)
P/Op Inc	15.0	MRK (9.4), UNH (11.9), TMUS (13.9), DIS (14.4), QCOM (14.5)

		Best Bets In Consumer Staples Sector
	CLX	MO	PM	MNST	PG	STZ	CL	HSY	KO	COCO	KVUE
What You Pay
P/E	19.1	12.7	29.3	38.1	21.5	19.4	22.3	24.8	21.9	34.9	21.7
P/EBIT	13.8	9.5	16.5	29.0	16.4	11.2	15.4	19.9	16.3	32.8	13.3
What You Get
Rev Chg Q	-18.9%	0.2%	9.4%	16.8%	3.0%	-15.0%	1.0%	26.0%	5.1%	37.2%	-3.5%
Rev Chg LTM	-9.3%	-0.2%	7.5%	7.6%	1.2%	-5.6%	0.1%	2.5%	2.8%	23.1%	-2.9%
Rev Chg 3Y Avg	-1.1%	-0.9%	8.0%	8.6%	1.8%	0.7%	4.2%	5.2%	4.0%	13.3%	0.2%
FCF/Rev 3Y Avg	9.9%	42.7%	24.9%	22.0%	18.0%	17.0%	15.4%	13.9%	13.9%	13.1%	11.9%

[1] Choosing top 10 best bets from each sector quarterly is an alpha producing strategy vs sector benchmark
[2] Historical annualized return of 8.7%, alpha of 1.4%, and sharpe of 0.5

Latest Trefis Analyses

	Title	Topic	Date
0	DASHBOARDS
1	Clorox Earnings Notes
2	Is Wall Street Underestimating Clorox Stock's Potential?	Actionable
3	5-Day Rally Sends Clorox Stock Up 9.5%	Notification
4	Clorox Stock: High Cash Flow - Why Not Watch It?	Actionable
5	How Low Can Clorox Stock Really Go?	Return
6	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/6/2025]	Notification
7	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/5/2025]	Notification
8	Day 5 of Gains Streak for Clorox Stock with 7.7% Return (vs. -20% YTD) [9/5/2025]	Notification
9	Clorox vs Merck: Which Is A Better Investment?	Counter-Intuitive Comparisons
10	Clorox vs Coca-Cola Consolidated: Which Is A Better Investment?	Counter-Intuitive Comparisons
11	ARTICLES
12	Could You Be Missing Clorox Stock’s Upside?		December 12th, 2025
13	Could You Be Missing Clorox Stock’s Upside?		November 27th, 2025
14	Clorox Stock Rockets 9.5% With 5-Day Winning Streak		November 27th, 2025
15	Is Clorox Stock Poised for a Rally?		November 12th, 2025
16	S&P 500 Stocks Trading At 52-Week Low		November 11th, 2025

	Title
0	DASHBOARDS
1	Clorox Earnings Notes
2	Is Wall Street Underestimating Clorox Stock's Potential?
3	5-Day Rally Sends Clorox Stock Up 9.5%
4	Clorox Stock: High Cash Flow - Why Not Watch It?
5	How Low Can Clorox Stock Really Go?
6	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/6/2025]
7	Day 5 of Gains Streak for Clorox Stock with 7.5% Return (vs. -20% YTD) [9/5/2025]
8	Day 5 of Gains Streak for Clorox Stock with 7.7% Return (vs. -20% YTD) [9/5/2025]
9	Clorox vs Merck: Which Is A Better Investment?
10	Clorox vs Coca-Cola Consolidated: Which Is A Better Investment?
11	ARTICLES
12	Could You Be Missing Clorox Stock’s Upside?
13	Could You Be Missing Clorox Stock’s Upside?
14	Clorox Stock Rockets 9.5% With 5-Day Winning Streak
15	Is Clorox Stock Poised for a Rally?
16	S&P 500 Stocks Trading At 52-Week Low

Trade Ideas

Select past ideas related to CLX. For more, see Trefis Trade Ideas.

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
BF-B_11302025_Dip_Buyer_ValueBuy	11302025	BF-B	Brown-Forman	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.8%	5.8%	0.0%
CPB_11302025_Dip_Buyer_ValueBuy	11302025	CPB	Campbell's	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-5.9%	-5.9%	-7.5%
ENR_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	ENR	Energizer	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	15.4%	15.4%	-5.3%
FLO_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	FLO	Flowers Foods	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	6.7%	6.7%	-1.6%
CLX_11142025_Dip_Buyer_FCFYield	11142025	CLX	Clorox	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-3.7%	-3.7%	-5.1%

Unique Key	Date	Ticker	Company	Category	Trade Strategy	6M Fwd Rtn	12M Fwd Rtn	12M Max DD
BF-B_11302025_Dip_Buyer_ValueBuy	11302025	BF-B	Brown-Forman	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	5.8%	5.8%	0.0%
CPB_11302025_Dip_Buyer_ValueBuy	11302025	CPB	Campbell's	Dip Buy	DB \| P/E OPMDip Buy with Low PE and High Margin Buying dips for companies with tame PE and meaningfully high operating margin	-5.9%	-5.9%	-7.5%
ENR_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	ENR	Energizer	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	15.4%	15.4%	-5.3%
FLO_11212025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG	11212025	FLO	Flowers Foods	Dip Buy	DB \| FCF Yield \| Low D/EDip Buy with High Free Cash Flow Yield Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap	6.7%	6.7%	-1.6%
CLX_11142025_Dip_Buyer_FCFYield	11142025	CLX	Clorox	Dip Buy	DB \| FCFY OPMDip Buy with High FCF Yield and High Margin Buying dips for companies with high FCF yield and meaningfully high operating margin	-3.7%	-3.7%	-5.1%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
UDMY	Udemy	0.9	12.7%	-26.5%
TWO	Two Harbors Investment	1.2	12.1%	8.5%
IOVA	Iovance Biotherapeutics	0.9	12.0%	-65.9%
KOD	Kodiak Sciences	1.4	11.8%	171.1%
RXRX	Recursion Pharmaceuticals	2.1	11.4%	-30.8%
TTC	Toro	7.9	10.7%	2.0%
HUT	Hut 8	4.2	9.0%	96.0%
TPL	Texas Pacific Land	20.3	7.6%	-19.7%
AXGN	Axogen	1.5	7.0%	90.5%
SSII	SS Innovations International	1.1	6.7%	-25.6%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
NOW	ServiceNow	32.5	-80.0%	-85.2%
FDMT	4D Molecular Therapeutics	0.5	-20.1%	65.4%
IMNM	Immunome	1.7	-15.8%	86.3%
HNRG	Hallador Energy	0.7	-15.2%	51.2%
AMPX	Amprius Technologies	1.1	-14.6%	213.6%
BNTC	Benitec Biopharma	0.4	-13.1%	-14.6%
FLNC	Fluence Energy	2.4	-12.9%	16.9%
IMSR	Terrestrial Energy	0.7	-12.6%
BE	Bloom Energy	18.1	-12.1%	246.6%
BW	Babcock & Wilcox Enterprises	0.5	-12.1%	182.9%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TLRY	Tilray Brands	13.7	55.9%	-3.2%
PL	Planet Labs PBC	5.0	27.3%	307.7%
EEX	Emerald	0.9	25.9%	-2.8%
EVCM	EverCommerce	2.2	17.2%	10.4%
CNL	Collective Mining	1.1	15.8%	229.3%
ENVA	Enova International	4.1	15.8%	70.8%
IMVT	Immunovant	4.6	14.5%	8.9%
QURE	uniQure	1.3	14.3%	30.4%
INNV	InnovAge	0.8	14.2%	49.6%
PGEN	Precigen	1.2	13.4%	255.4%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
NOW	ServiceNow	32.5	-81.7%	-85.2%
RZLT	Rezolute	0.2	-81.6%	-59.0%
FRMI	Fermi	6.3	-41.1%
LENZ	LENZ Therapeutics	0.5	-34.6%	-43.3%
BETR	Better Home & Finance	0.5	-30.9%	292.0%
LWLG	Lightwave Logic	0.4	-29.5%	41.4%
APLD	Applied Digital	5.6	-29.0%	188.0%
CRWV	CoreWeave	31.4	-26.8%
WULF	TeraWulf	4.5	-26.6%	104.4%
BW	Babcock & Wilcox Enterprises	0.5	-26.5%	182.9%

1 Month Top Gainers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
OLMA	Olema Pharmaceuticals	2.8	282.6%	459.2%
WVE	WAVE Life Sciences	2.7	128.5%	32.1%
ALMS	Alumis	0.8	89.8%	34.6%
NUVB	Nuvation Bio	2.9	82.4%	220.3%
SEMR	SEMrush	1.8	75.7%	-0.2%
TE	T1 Energy	0.8	70.4%
ANF	Abercrombie & Fitch	5.6	68.4%	-21.6%
CBLL	CeriBell	0.8	67.5%	-16.6%
FTRE	Fortrea	1.5	65.4%	-13.2%
VERA	Vera Therapeutics	3.1	64.7%	14.8%

1 Month Top Losers

Ticker	Company	Mkt Cap (B)	1M Rtn	YTD Rtn
NOW	ServiceNow	32.5	-81.3%	-85.2%
RZLT	Rezolute	0.2	-80.3%	-59.0%
JANX	Janux Therapeutics	0.9	-50.9%	-73.7%
FRMI	Fermi	6.3	-50.6%
AGIO	Agios Pharmaceuticals	1.5	-43.6%	-22.6%
IMSR	Terrestrial Energy	0.7	-38.9%
LENZ	LENZ Therapeutics	0.5	-36.3%	-43.3%
LWLG	Lightwave Logic	0.4	-36.3%	41.4%
UAMY	United States Antimony	0.5	-33.7%	156.5%
BETR	Better Home & Finance	0.5	-33.6%	292.0%

Recent Active Movers

1 Day Top Gainers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
UDMY	Udemy	0.9	12.7%	-26.5%
TWO	Two Harbors Investment	1.2	12.1%	8.5%
IOVA	Iovance Biotherapeutics	0.9	12.0%	-65.9%
KOD	Kodiak Sciences	1.4	11.8%	171.1%
RXRX	Recursion Pharmaceuticals	2.1	11.4%	-30.8%
TTC	Toro	7.9	10.7%	2.0%
HUT	Hut 8	4.2	9.0%	96.0%
TPL	Texas Pacific Land	20.3	7.6%	-19.7%
AXGN	Axogen	1.5	7.0%	90.5%
SSII	SS Innovations International	1.1	6.7%	-25.6%

1 Day Top Losers

Ticker	Company	Mkt Cap (B)	1D Rtn	YTD Rtn
NOW	ServiceNow	32.5	-80.0%	-85.2%
FDMT	4D Molecular Therapeutics	0.5	-20.1%	65.4%
IMNM	Immunome	1.7	-15.8%	86.3%
HNRG	Hallador Energy	0.7	-15.2%	51.2%
AMPX	Amprius Technologies	1.1	-14.6%	213.6%
BNTC	Benitec Biopharma	0.4	-13.1%	-14.6%
FLNC	Fluence Energy	2.4	-12.9%	16.9%
IMSR	Terrestrial Energy	0.7	-12.6%
BE	Bloom Energy	18.1	-12.1%	246.6%
BW	Babcock & Wilcox Enterprises	0.5	-12.1%	182.9%

1 Week Top Gainers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
TLRY	Tilray Brands	13.7	55.9%	-3.2%
PL	Planet Labs PBC	5.0	27.3%	307.7%
EEX	Emerald	0.9	25.9%	-2.8%
EVCM	EverCommerce	2.2	17.2%	10.4%
CNL	Collective Mining	1.1	15.8%	229.3%
ENVA	Enova International	4.1	15.8%	70.8%
IMVT	Immunovant	4.6	14.5%	8.9%
QURE	uniQure	1.3	14.3%	30.4%
INNV	InnovAge	0.8	14.2%	49.6%
PGEN	Precigen	1.2	13.4%	255.4%

1 Week Top Losers

Ticker	Company	Mkt Cap (B)	1W Rtn	YTD Rtn
NOW	ServiceNow	32.5	-81.7%	-85.2%
RZLT	Rezolute	0.2	-81.6%	-59.0%
FRMI	Fermi	6.3	-41.1%
LENZ	LENZ Therapeutics	0.5	-34.6%	-43.3%
BETR	Better Home & Finance	0.5	-30.9%	292.0%
LWLG	Lightwave Logic	0.4	-29.5%	41.4%
APLD	Applied Digital	5.6	-29.0%	188.0%
CRWV	CoreWeave	31.4	-26.8%
WULF	TeraWulf	4.5	-26.6%	104.4%
BW	Babcock & Wilcox Enterprises	0.5	-26.5%	182.9%

Peer Comparisons for Clorox

Peers to compare with:

Financials

	CLX	PG	CL	KMB	CHD	ECL	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Church &.	Ecolab
Mkt Price	101.52	147.81	79.73	102.94	86.52	261.89	102.23
Mkt Cap	12.4	346.2	64.6	34.2	21.2	74.2	49.4
Rev LTM	6,771	84,933	19,999	18,883	6,066	15,724	17,303
Op Inc LTM	1,009	20,509	4,346	3,160	1,079	2,718	2,939
FCF LTM	636	14,943	3,370	2,102	931	1,574	1,838
FCF 3Y Avg	700	15,127	3,028	2,456	865	1,658	2,057
CFO LTM	853	18,923	3,920	2,872	1,073	2,625	2,748
CFO 3Y Avg	916	18,616	3,659	3,221	1,059	2,531	2,876

Growth & Margins

	CLX	PG	CL	KMB	CHD	ECL	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Church &.	Ecolab
Rev Chg LTM	-9.3%	1.2%	0.1%	-3.1%	1.1%	0.6%	0.3%
Rev Chg 3Y Avg	-1.1%	1.8%	4.2%	-2.1%	4.6%	5.2%	3.0%
Rev Chg Q	-18.9%	3.0%	1.0%	-1.6%	-0.3%	1.0%	0.3%
QoQ Delta Rev Chg LTM	-4.7%	0.8%	0.3%	-0.4%	-0.1%	0.3%	0.1%
Op Mgn LTM	14.9%	24.1%	21.7%	16.7%	17.8%	17.3%	17.5%
Op Mgn 3Y Avg	12.6%	23.6%	21.2%	15.2%	18.3%	15.2%	16.8%
QoQ Delta Op Mgn LTM	-1.7%	-0.1%	-0.1%	0.3%	-1.2%	0.4%	-0.1%
CFO/Rev LTM	12.6%	22.3%	19.6%	15.2%	17.7%	16.7%	17.2%
CFO/Rev 3Y Avg	12.9%	22.2%	18.7%	16.5%	18.0%	16.4%	17.2%
FCF/Rev LTM	9.4%	17.6%	16.9%	11.1%	15.3%	10.0%	13.2%
FCF/Rev 3Y Avg	9.9%	18.0%	15.4%	12.5%	14.7%	10.8%	13.6%

Valuation

	CLX	PG	CL	KMB	CHD	ECL	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Church &.	Ecolab
Mkt Cap	12.4	346.2	64.6	34.2	21.2	74.2	49.4
P/S	2.2	4.2	3.2	2.2	3.5	4.9	3.4
P/EBIT	13.8	16.4	15.4	13.6	27.6	25.8	15.9
P/E	19.1	21.5	22.3	17.0	40.8	36.3	21.9
P/CFO	17.7	19.0	16.5	14.4	20.0	29.6	18.4
Total Yield	7.2%	4.7%	7.3%	9.9%	3.1%	3.7%	5.9%
Dividend Yield	2.0%	0.0%	2.8%	4.0%	0.7%	0.9%	1.4%
FCF Yield 3Y Avg	4.1%	4.1%	4.4%	5.6%	3.8%	2.5%	4.1%
D/E	0.2	0.1	0.1	0.2	0.1	0.1	0.1
Net D/E	0.2	0.1	0.1	0.2	0.1	0.1	0.1

Returns

	CLX	PG	CL	KMB	CHD	ECL	Median
Name	Clorox	Procter .	Colgate-.	Kimberly.	Church &.	Ecolab
1M Rtn	0.3%	1.4%	1.2%	0.5%	4.2%	2.8%	1.3%
3M Rtn	-18.2%	-7.2%	-2.4%	-17.0%	-5.6%	-1.0%	-6.4%
6M Rtn	-14.3%	-5.2%	-8.4%	-17.8%	-9.2%	1.2%	-8.8%
12M Rtn	-35.5%	-10.9%	-12.7%	-18.3%	-17.2%	7.5%	-14.9%
3Y Rtn	-22.2%	6.0%	10.1%	-14.8%	11.9%	88.4%	8.0%
1M Excs Rtn	-0.4%	0.6%	0.4%	-0.2%	3.5%	2.1%	0.5%
3M Excs Rtn	-18.7%	-6.7%	-2.9%	-18.3%	-7.0%	-2.2%	-6.9%
6M Excs Rtn	-26.7%	-17.5%	-20.8%	-30.2%	-21.5%	-11.2%	-21.2%
12M Excs Rtn	-47.2%	-22.4%	-23.7%	-29.5%	-28.1%	-5.1%	-25.9%
3Y Excs Rtn	-93.4%	-63.9%	-59.5%	-84.9%	-58.0%	11.9%	-61.7%

Comparison Analyses

	Title
0	How Does Clorox Stock Stack Up Against Its Peers?
1	Why CLX With 9.4% Upside May Beat KMB?
2	CLX Looks Stronger Than EPC With 9.4% Return Potential
3	CL Could Deliver 11% Returns And Outperform CLX
4	Clorox vs. Fortinet: With Return Forecast Of 31%, Fortinet Is A Better Bet
5	Clorox vs. Keurig Dr Pepper: With Return Forecast Of 83%, Keurig Dr Pepper Is A Better Bet
6	Clorox vs. Veeva Systems: With Return Forecast Of 66%, Veeva Systems Is A Better Bet
7	Clorox vs. Ross Stores: With Return Forecast Of 37%, Ross Stores Is A Better Bet
8	Clorox vs. Exelon: With Return Forecast Of 21%, Clorox Is A Better Bet
9	Clorox vs. Zoetis: Similar Revenue, Similar Bets

Financials

Annual
Quarterly

$ Mil \| FY: 6/30	LTM	2025	2024	2023	2022	2021	2020
Period End	9/30/2025	6/30/2025	6/30/2024	6/30/2023	6/30/2022	6/30/2021	6/30/2020
Filing Date	11/3/2025	8/8/2025	8/8/2024	8/10/2023	8/10/2022	8/10/2021	8/13/2020
Key Financials
Total Revenue	6,771	7,104	7,093	7,389	7,107	7,341	6,721
EBITDA	1,319	1,385	723	564	937	1,210	1,464
Operating Income	1,009	1,177	723	823	719	1,225	1,261
Net Income	791	810	280	149	462	710	939
EPS	6.41	6.56	2.26	1.21	3.75	5.66	7.46
Growth Rates
Total Revenue Growth	-9.3%	0.2%	-4.0%	4.0%	-3.2%	9.2%	8.2%
EBITDA Growth	52.7%	91.6%	28.2%	-39.8%	-22.6%	-17.3%	12.5%
Operating Income Growth	5.4%	62.8%	-12.2%	14.5%	-41.3%	-2.9%	13.9%
Net Income Growth	121.6%	189.3%	87.9%	-67.7%	-34.9%	-24.4%	14.5%
Margins
EBITDA Margin	19.5%	19.5%	10.2%	7.6%	13.2%	16.5%	21.8%
Operating Income Margin	14.9%	16.6%	10.2%	11.1%	10.1%	16.7%	18.8%
Net Income Margin	11.7%	11.4%	3.9%	2.0%	6.5%	9.7%	14.0%
Cash & Debt
Total Cash	166	167	202	367	183	319	871
Total Debt	3,078	2,880	2,903	2,924	3,103	3,166	3,122
Net Debt / (Cash)	2,912	2,713	2,701	2,557	2,920	2,847	2,251
Cash Flows
Net Cash from Operations	853	981	695	1,158	786	1,276	1,546
Free Cash from Operations	636	761	483	930	535	945	1,292
Returns to Shareholders
Dividends	602	602	595	583	571	558	533
Share Repurchases	354	332	-0	-0	25	905	248

$ Mil \| FY: 6/30	2026Q1	2025Q4	2025Q3	2025Q2	2025Q1	2024Q4	2024Q3	2024Q2	2024Q1	2023Q4	2023Q3	2023Q2
Period End	9/30/2025	6/30/2025	3/31/2025	12/31/2024	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023	3/31/2023	12/31/2022
Filing Date	11/3/2025	8/8/2025	5/5/2025	2/3/2025	10/30/2024	8/8/2024	4/30/2024	2/1/2024	11/1/2023	8/10/2023	5/2/2023	2/2/2023
Key Financials Quarterly
Total Revenue	1,429	1,988	1,668	1,686	1,762	1,903	1,814	1,990	1,386	2,019	1,915	1,715
Ebitda	186	489	332	312	252	355	38	219	111	320	-161	211
Operating Income	120	420	238	231	288	310	211	148	62	254	248	149
Net Income	80	332	186	193	99	216	-51	93	22	176	-211	99
EPS	0.65	2.70	1.51	1.55	0.80	1.74	-0.41	0.75	0.17	1.43	-1.71	0.81
Key Financials TTM
Total Revenue TTM	6,771	7,104	7,019	7,165	7,469	7,093	7,209	7,310	7,035	7,389	7,171	7,065
Ebitda TTM	1,319	1,385	1,251	957	864	723	688	489	481	564	467	906
Operating Income TTM	1,009	1,177	1,067	1,040	957	731	675	712	713	823	721	705
Net Income TTM	791	810	694	457	357	280	240	80	86	149	74	435
Growth Rates Quarterly
Total Revenue Growth	-18.9%	4.5%	-8.0%	-15.3%	27.1%	-5.7%	-5.3%	16.0%	-20.3%	12.1%	5.9%	1.4%
EBITDA Growth	-26.2%	37.7%	773.7%	42.5%	127.0%	10.9%	123.6%	3.8%	-42.8%	43.5%	-157.9%	23.4%
Operating Income Growth	-58.3%	35.5%	12.8%	56.1%	364.5%	22.0%	-14.9%	-0.7%	-64.0%	67.1%	6.9%	28.4%
Net Income Growth	-19.2%	53.7%	464.7%	107.5%	350.0%	22.7%	75.8%	-6.1%	-74.1%	74.3%	-240.7%	43.5%
Margins Quarterly
EBITDA Margin	13.0%	24.6%	19.9%	18.5%	14.3%	18.7%	2.1%	11.0%	8.0%	15.8%	-8.4%	12.3%
Operating Income Margin	8.4%	21.1%	14.3%	13.7%	16.3%	16.3%	11.6%	7.4%	4.5%	12.6%	13.0%	8.7%
Net Income Margin	5.6%	16.7%	11.2%	11.4%	5.6%	11.4%	-2.8%	4.7%	1.6%	8.7%	-11.0%	5.8%
Cash & Debt
Total Cash	166	167	226	290	278	202	219	355	518	367	242	168
Total Debt	3,078	2,880	2,944	3,092	2,884	2,903	3,020	3,129	3,203	2,924	3,025	3,083
Net Debt / (Cash)	2,912	2,713	2,718	2,802	2,606	2,701	2,801	2,774	2,685	2,557	2,783	2,915
Cash Flows Quarterly
FCF from Operations	93	294	286	180	221	340	182	153	20	430	341	209
Cash Flows TTM
FCF from Operations TTM	853	981	1,027	923	896	695	785	944	1,000	1,158	1,063	951
Returns to Shareholders Quarterly
Dividends	151	150	150	151	151	149	148	149	149	146	146	146
Share Repurchases	129	75	-0	150	107	-0	-0	-0	-0	-0	-0	-0
Return on Invested Capital (ROIC) Quarterly
ROIC	12.6%	50.7%	26.3%	27.0%	25.7%	36.9%	30.1%	15.1%	8.0%	30.3%	30.4%	16.0%
Return on Invested Capital (ROIC) TTM
ROIC TTM	27.6%	33.2%	29.5%	26.8%	24.9%	19.9%	16.9%	15.2%	17.4%	21.8%	16.7%	18.7%

Segment Financials

Revenue by Segment

$ Mil	2025	2024	2023	2022	2021
Health and Wellness	2,485	2,532	2,427	2,980	2,749
Household	1,950	2,098	1,984	1,981	1,795
Lifestyle	1,275	1,338	1,253	1,218	1,154
International	1,162	1,181	1,180	1,162	1,023
Corporate and Other	221	240	263
Total	7,093	7,389	7,107	7,341	6,721

Assets by Segment

$ Mil	2025	2024	2023	2022	2021
International	1,327	1,410	1,453	1,489	1,010
Health and Wellness	1,124	1,184	1,275	2,043	2,145
Lifestyle	1,110	1,091	1,035	1,011	956
Corporate and Other	1,102	1,178	1,350	879	1,292
Household	1,088	1,082	1,045	912	810
Total	5,751	5,945	6,158	6,334	6,213

Price Behavior

Price Behavior

Market Price	$101.52
Market Cap ($ Bil)	12.4
First Trading Date	03/21/1983
Distance from 52W High	-35.9%
	50 Days	200 Days
DMA Price	$108.75	$123.26
DMA Trend	down	down
Distance from DMA	-6.7%	-17.6%
	3M	1YR
Volatility	23.9%	23.2%
Downside Capture	29.05	43.15
Upside Capture	-75.15	-5.28
Correlation (SPY)	0.9%	19.9%

CLX Betas & Captures as of 11/30/2025

	1M	2M	3M	6M	1Y	3Y
Beta	0.30	0.02	-0.03	0.29	0.23	0.24
Up Beta	0.84	1.14	1.34	0.86	0.32	0.43
Down Beta	-0.96	-0.07	0.16	0.19	0.21	0.12
Up Capture	-3%	-64%	-55%	-11%	-5%	2%
Bmk +ve Days	12	25	38	73	141	426
Stock +ve Days	8	16	27	56	118	373
Down Capture	57%	11%	-40%	51%	46%	47%
Bmk -ve Days	7	16	24	52	107	323
Stock -ve Days	10	24	34	68	129	375

[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively

1Y 5Y 10Y

Based On 1-Year Data

		Comparison of CLX With Other Asset Classes (Last 1Y)
	CLX	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-36.0%	-1.2%	12.1%	61.5%	2.2%	-2.2%	-12.7%
Annualized Volatility	23.1%	14.0%	19.7%	19.3%	15.9%	17.7%	35.4%
Sharpe Ratio	-1.99	-0.32	0.46	2.36	-0.05	-0.28	-0.17
Correlation With Other Assets		63.0%	19.5%	-3.8%	-2.8%	45.0%	10.6%

ETFs used for asset classes: Sector ETF = XLP, Equity = SPY, Gold = GLD, Commodities = DBC, Real Estate = VNQ, and Bitcoin = BTCUSD
Smart multi-asset allocation framework can stack odds in your favor. Learn How

Based On 5-Year Data

		Comparison of CLX With Other Asset Classes (Last 5Y)
	CLX	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	-9.9%	6.0%	14.4%	18.3%	11.4%	4.8%	36.3%
Annualized Volatility	25.1%	13.0%	17.1%	15.5%	18.9%	18.9%	48.9%
Sharpe Ratio	-0.42	0.26	0.68	0.95	0.49	0.17	0.63
Correlation With Other Assets		52.5%	18.0%	-0.5%	-8.6%	27.7%	2.0%

Based On 10-Year Data

		Comparison of CLX With Other Asset Classes (Last 10Y)
	CLX	Sector ETF	Equity	Gold	Commodities	Real Estate	Bitcoin
Annualized Return	0.5%	7.5%	14.5%	14.6%	6.1%	5.4%	70.7%
Annualized Volatility	23.7%	14.7%	18.0%	14.7%	17.7%	20.8%	55.9%
Sharpe Ratio	0.03	0.39	0.69	0.82	0.27	0.23	0.91
Correlation With Other Assets		54.4%	23.1%	3.6%	-4.2%	28.0%	2.9%

Short Interest

Short Interest: As Of Date	11282025
Short Interest: Shares Quantity	6,853,224
Short Interest: % Change Since 11152025	1.6%
Average Daily Volume	2,689,899
Days-to-Cover Short Interest	2.55
Basic Shares Quantity	122,629,000
Short % of Basic Shares	5.6%

Returns Analyses

	Title
0	How Low Can Clorox Stock Really Go?
1	CLX YTD Stock Return Of -100% Underperforms CL by 0% and Underperforms CL by 0%
2	Clorox Stock Return Comparison
3	Clorox Total Shareholder Return (TSR): 16.2% in 2023 and -7.5% 3-yr returns (below peer average)

Earnings Returns History

Expand for More

	Forward Returns
Earnings Date	1D Returns	5D Returns	21D Returns
11/3/2025	1.2%	-4.1%	-3.7%
7/31/2025	-2.0%	0.4%	-4.9%
5/5/2025	-2.4%	-0.2%	-6.3%
2/3/2025	-7.2%	-7.9%	-6.3%
10/30/2024	1.3%	4.0%	6.8%
8/1/2024	7.4%	7.6%	19.0%
4/30/2024	-5.6%	-4.5%	-12.7%
2/1/2024	5.6%	4.2%	2.0%
...
SUMMARY STATS
# Positive	13	15	11
# Negative	11	9	13
Median Positive	4.7%	5.8%	6.8%
Median Negative	-5.6%	-4.5%	-5.5%
Max Positive	9.8%	14.3%	24.7%
Max Negative	-14.5%	-14.5%	-12.7%

SEC Filings

Expand for More

Report Date	Filing Date	Filing
9302025	11032025	10-Q 9/30/2025
6302025	8082025	10-K 6/30/2025
3312025	5052025	10-Q 3/31/2025
12312024	2032025	10-Q 12/31/2024
9302024	10302024	10-Q 9/30/2024
6302024	8082024	10-K 6/30/2024
3312024	4302024	10-Q 3/31/2024
12312023	2012024	10-Q 12/31/2023
9302023	11012023	10-Q 9/30/2023
6302023	8102023	10-K 6/30/2023
3312023	5022023	10-Q 3/31/2023
12312022	2022023	10-Q 12/31/2022
9302022	11012022	10-Q 9/30/2022
6302022	8102022	10-K 6/30/2022
3312022	5022022	10-Q 3/31/2022
12312021	2032022	10-Q 12/31/2021

External Quote Links

0	Y Finance	Barrons
1	TradingView	Morningstar
2	SeekingAlpha	ValueLine
3	Motley Fool	Robinhood
4	CNBC	Etrade
5	MarketWatch	Unusual Whales
6	YCharts	Perplexity Finance
7	FinViz

Prefer one of these to Trefis? Tell us why.

Clorox (CLX)

Market Price (12/18/2025): $101.5 | Market Cap: $12.4 BilSector: Consumer Staples | Industry: Household Products

Clorox (CLX)

Market Price (12/18/2025): $101.5Market Cap: $12.4 BilSector: Consumer StaplesIndustry: Household Products

Valuation, Metrics & Events

CLX Stock

Why The Stock Moved

Qualitative Assessment

Stock Movement Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Fundamental Drivers

Market Drivers

Return vs. Risk

Price Returns Compared

How Low Can It Go

In The Past

Preserve Wealth

Asset Allocation

About Clorox (CLX)

Key Risks to Clorox (CLX)

Share Repurchases

Share Issuance

Outbound Investments

Capital Expenditures

Interactive Breakdown

Better Bets than Clorox (CLX)

Latest Trefis Analyses

Trade Ideas

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

1 Month Top Gainers

1 Month Top Losers

Recent Active Movers

1 Day Top Gainers

1 Day Top Losers

1 Week Top Gainers

1 Week Top Losers

More From Trefis

Research & Analysis

Invest in Strategies

Wealth Management

Peer Comparisons for Clorox

Financials

Growth & Margins

Valuation

Returns

Comparison Analyses

FDIC Bank Data

Bank Capital

Bank Deposits

Bank Assets

Bank Loans

Financials

Segment Financials

Price Behavior

Based On 1-Year Data

Based On 5-Year Data

Based On 10-Year Data

Short Interest

Returns Analyses

Earnings Returns History

SEC Filings

Insider Activity

Industry Resources

External Quote Links

Market Price (12/18/2025): $101.5 | Market Cap: $12.4 Bil
Sector: Consumer Staples | Industry: Household Products

Market Price (12/18/2025): $101.5
Market Cap: $12.4 Bil
Sector: Consumer Staples
Industry: Household Products